Home > Specialists > Breast Surgery > Dr. Changjun Wang (王常珺)
Specialty & Clinical Focus:
Dr. Changjun Wang is a breast surgery specialist at Peking Union Medical College Hospital (PUMCH) in Beijing, with a clinical focus on breast cancer surgery, breast-conserving procedures, sentinel lymph node biopsy, breast reconstruction, and precision medicine.
Professional Title & Qualifications:
Associate Chief Physician
Associate Professor
M.D., Ph.D. in Clinical Medicine (Peking Union Medical College)
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) – Department of Breast Surgery
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Changjun Wang (王常珺) - Breast Surgery Specialist
Personal Biography
Dr. Changjun Wang is an Associate Chief Physician and Associate Professor in the Department of Breast Surgery at Peking Union Medical College Hospital (PUMCH) in Beijing. With nearly 20 years of clinical experience, he focuses on the diagnosis and surgical treatment of breast diseases, including breast cancer surgery, breast-conserving procedures, sentinel lymph node biopsy, and breast reconstruction.
Dr. Wang completed the eight-year Clinical Medicine Program at Peking Union Medical College, earning his M.D. and Ph.D. in 2007. His academic work includes precision medicine for breast cancer, HER2-positive breast cancer therapies, and non-invasive evaluation of axillary lymph node burden, alongside clinical research and surgical education.
Why Access Dr. Wang via MedBridgeNZ
International patients seeking a specialist review for breast cancer surgery or reconstruction may value Dr. Wang’s combination of nearly 20 years of clinical experience, training at Peking Union Medical College, and current role in the Department of Breast Surgery at PUMCH. His work spans breast-conserving surgery, sentinel lymph node biopsy, breast reconstruction, and precision medicine.
A remote specialist-review pathway can help organize the patient’s medical records, prior treatment history, and key questions before travel. MedBridgeNZ supports record preparation, translation coordination, and communication with Dr. Wang’s specialist office so the submitted case can be reviewed and the patient can receive his opinion, recommendations, and responses through the arranged pathway before deciding whether to pursue in-person care in Beijing.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel, international patients can request MedBridgeNZ coordination for a remote pre-travel specialist review with Dr. Changjun Wang. We organize the medical records, prior treatment history, and questions authorized for review, coordinate translation where needed, transfer the documents securely to the specialist office, and manage review-related communication.
Once the review pathway is accepted and arranged, Dr. Wang will review the submitted records and provide his specialist opinion, recommendations, and responses to the patient’s questions. This gives the patient clearer information for deciding whether to pursue an in-person appointment and medical travel to Beijing before making major logistical commitments.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Changjun Wang
Areas of Expertise
Breast Cancer Management: Comprehensive diagnosis and treatment of benign and malignant breast conditions.
Surgical Oncology: Proficiency in modified radical mastectomy and breast-conserving surgeries (lumpectomy).
Sentinel Lymph Node Biopsy: Advanced, minimally invasive techniques for accurate lymph node staging.
Breast Reconstruction: Integrated surgical planning for post-mastectomy rehabilitation and aesthetic recovery.
Precision Medicine: Tailored adjuvant therapies (chemotherapy, targeted therapy) based on molecular subtypes (e.g., HER2-positive).
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 4.8/5.0 Overall Rating
* Treatment Pathway Satisfaction:
4.8/5.0
* Communication & Professionalism:
4.8/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
17,300 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2017 – Present: Associate Chief Physician, Department of Breast Surgery, Peking Union Medical College Hospital (PUMCH).
2009 – 2017: Attending Physician, Department of Breast Surgery, PUMCH.
2007 – 2009: Resident Physician, PUMCH.
Education & Training
2007: M.D. and Ph.D., 8-year Clinical Medicine Program, Peking Union Medical College.
Awards & Honors
Academic & Professional Memberships
Youth Committee Member, Chinese Research Hospital Association (CRHA).
Youth Committee Member, Beijing Breast Disease Prevention and Treatment Society.
Research & Publications
Conducted significant research on HER2-positive breast cancer therapies and non-invasive diagnostic tools for axillary lymph node evaluation.
Authored and published multiple academic papers in prominent journals, including Scientific Reports and the Medical Journal of Peking Union Medical College Hospital.
Contributed to optimizing clinical workflows, specifically studying the “Doctor-Nurse Integrated Model” to enhance safety and efficiency in chemotherapy management.
Selected Peer-Reviewed Publications
Selected peer-reviewed publications by Dr. Changjun Wang include:
Wang C, et al. Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis. Breast Cancer. 2022;29(2):314–323. PMID: 34766244.
Wang C, et al. Prognostic Value of PD-L1 in Breast Cancer: A Meta-Analysis. Breast J. 2017;23(4):436–443. PMID: 28079291.
Liu Y, Wang C, et al. Deep learning assisted non-invasive lymph node burden evaluation and CDK4/6i administration in luminal breast cancer. iScience. 2025;28(7):112849. PMID: 40678544.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Wang review my breast condition before I travel to China?
Dr. Changjun Wang’s clinical focus includes breast cancer management, breast-conserving surgery, sentinel lymph node biopsy, breast reconstruction, and precision medicine. MedBridgeNZ can coordinate a remote pre-travel specialist-review pathway by preparing and translating the records you authorize for submission and arranging communication with his specialist office. Once the review is accepted and scheduled, Dr. Wang will examine the submitted materials, provide his specialist opinion and recommendations, and respond to the patient’s questions. His review can help the patient understand possible next steps before deciding whether to pursue an in-person appointment in Beijing.
How can an international patient request an appointment with Dr. Wang at PUMCH?
International appointment requests at Peking Union Medical College Hospital can involve registration, document preparation, and Chinese-language communication. MedBridgeNZ coordinates the request process by organizing the patient’s records, coordinating translation, transferring client-authorized documents, and communicating with the relevant specialist office. Where a pre-travel review forms part of the pathway, the records are prepared for Dr. Wang’s review before travel. After the specialist office confirms the available pathway, we assist with the related scheduling communication and practical preparation for the patient’s visit to Beijing.
What support is available if I travel to Beijing for further care?
If the specialist review supports an in-person pathway and the patient chooses to proceed, MedBridgeNZ can coordinate the practical arrangements around the hospital visit. Support can include appointment communication, medical invitation or visa-document coordination, travel planning, translation coordination, and non-clinical bilingual administrative assistance during hospital procedures. We also help keep the patient’s records and questions organized for the visit. The specialist and hospital remain responsible for clinical decisions, treatment planning, and medical recommendations.
How are language barriers handled during the remote review and hospital visit?
MedBridgeNZ coordinates medical-document translation and bilingual communication throughout the arranged pathway. Before the remote review, we help prepare translated records and a clear list of the patient’s questions for submission. During appointment communication and an in-person hospital visit, non-clinical bilingual support can help the patient follow registration, admission, and other administrative steps so questions can be accurately relayed to the specialist team. The goal is to reduce communication friction and help the patient understand the information provided by Dr. Wang and PUMCH.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. For patients seeking access to Dr. Changjun Wang at PUMCH, we assist with medical-record preparation, translation coordination, client-authorized document transfer, appointment request communication, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment. Hospital, specialist, diagnostic, treatment, travel, and other third-party costs remain separate from MedBridgeNZ coordination fees unless expressly stated otherwise in writing.